Novartis AG
SWX:NOVN
CHF 89.12
+ CHF0.18 (0.20%)
CHF 89.12
+ CHF0.18 (0.20%)
End-of-day quote: 04/24/2024

NOVN - Novartis Stock Prediction 2025 - 2030

20 years of reliable Novartis stock forecast. The Wall Street analysts predict Hold for NOVN. See at a glance whether SWX:NOVN will rise in the future.

CHF86.96
Forecast 2023
CHF105.64
Forecast 2025
CHF105.50
Forecast 2030
Outperform
TopGraphs Quality Ranking
Forecast 2023
CHF86.96
Forecast 2025
CHF105.64
Forecast 2030
CHF105.50
TopGraphs Quality Ranking
Outperform

Company Info

P/E
0.00
Beta
0.47
Price-to-book Ratio
3.90
Market Cap
181.47B
TEV
197.46 B
Dividend
CHF3.31
Div Yld
3.71%
Forecast 1Y
13.60%
Forecast 2Y
27.68%
Analyst Price Target
CHF105.00
Website

Novartis Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Novartis Stock Forecast 2023

CHF105.90

In the last five quarters, Novartis’s Price Target has risen from CHF86.28 to CHF105.00 - a 21.7% increase. Sixteen analysts predict that Novartis’s share price will increase in the coming year, reaching CHF105.90. This would represent an increase of 0.86%.

18.83%
18.83
Last update: 04/24/2024

Highest Price Target CHF130.68

Average Price Target CHF105.90

Lowest Price Target CHF81.17

Novartis Stock Predictions 2025

Stock Forecast for the Price of an Novartis Share in Jan 2025.

In January 2025, analysts believe the stock price will be CHF97.75. An increase of 9.69% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Feb 2025.

In February 2025, analysts believe the stock price will be CHF98.47. An increase of 10.49% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Mar 2025.

In March 2025, analysts believe the stock price will be CHF99.19. An increase of 11.3% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Apr 2025.

In April 2025, analysts believe the stock price will be CHF99.90. An increase of 12.1% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in May 2025.

In May 2025, analysts believe the stock price will be CHF100.62. An increase of 12.9% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Jun 2025.

In June 2025, analysts believe the stock price will be CHF101.34. An increase of 13.71% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Jul 2025.

In July 2025, analysts believe the stock price will be CHF102.05. An increase of 14.51% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Aug 2025.

In August 2025, analysts believe the stock price will be CHF102.77. An increase of 15.32% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Sep 2025.

In September 2025, analysts believe the stock price will be CHF103.49. An increase of 16.12% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Oct 2025.

In October 2025, analysts believe the stock price will be CHF104.20. An increase of 16.93% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Nov 2025.

In November 2025, analysts believe the stock price will be CHF104.92. An increase of 17.73% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Dec 2025.

In December 2025, analysts believe the stock price will be CHF105.64. An increase of 18.54% compared to the previous month's estimate.

Novartis Stock Prediction 2030

Stock Prediction for the Price of One Novartis Share in Jan 2030.

In Jan 2030 analysts predict a share price of CHF105.63. An increase of 18.52% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Feb 2030.

In Feb 2030 analysts predict a share price of CHF105.62. An increase of 18.51% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Mar 2030.

In Mar 2030 analysts predict a share price of CHF105.60. An increase of 18.5% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Apr 2030.

In Apr 2030 analysts predict a share price of CHF105.59. An increase of 18.48% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in May 2030.

In May 2030 analysts predict a share price of CHF105.58. An increase of 18.47% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Jun 2030.

In Jun 2030 analysts predict a share price of CHF105.57. An increase of 18.46% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Jul 2030.

In Jul 2030 analysts predict a share price of CHF105.56. An increase of 18.45% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Aug 2030.

In Aug 2030 analysts predict a share price of CHF105.55. An increase of 18.43% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Sep 2030.

In Sep 2030 analysts predict a share price of CHF105.54. An increase of 18.42% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Oct 2030.

In Oct 2030 analysts predict a share price of CHF105.53. An increase of 18.41% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Nov 2030.

In Nov 2030 analysts predict a share price of CHF105.52. An increase of 18.4% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Dec 2030.

In Dec 2030 analysts predict a share price of CHF105.50. An increase of 18.38% compared to today's share price.

P/E
0.00
Beta
0.47
Price-to-book Ratio
3.90
Market Cap
181.47B
TEV
197.46 B
Dividend
CHF3.31
Div Yld
3.71%
Forecast 1Y
13.60%
Forecast 2Y
27.68%
Analyst Price Target
CHF105.00
Website

Novartis Analyst Ratings Frequently Asked Questions

Who are the analysts watching Novartis AG?

The following analysts have recently covered Novartis:

Argus Research Company
Axia Financial Research
Barclays
Berenberg
BNP Paribas Exane
BofA Global Research
CFRA Equity Research
Citigroup Inc
Citigroup Inc. Research
Deutsche Bank
Guggenheim Securities, LLC
HSBC
J.P. Morgan
Jefferies LLC
Kepler Cheuvreux
Marktfeld
Morgan Stanley
Morningstar Inc.
ODDO BHF Corporate & Markets
S&P Global Ratings
Stifel
UBS Investment Bank
Wolfe Research, LLC.
Zürcher Kantonalbank
Baptista Research
Crisp Idea
Equisights
Mirae Asset Securities Co., Ltd.
Redburn Atlantic
TD Cowen
BMO Capital Markets Equity Research
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Novartis AG?

The following sell-side analysts have recently covered Novartis:

Hellweg, Jasper
Spagna, Fabrizio
Field, Emily
Holford, Kerry Ann
Parkes, Richard J.
Parry, Graham Glyn Charles
Nurhayati, Wan
Baum, Andrew Simon
Scala, Stephen Michael
Papadakis, Emmanuel Douglas
Fernandez, Seamus Christopher
Mead, Julie
Welford, Peter James
Evans, David Paul
Paraskevopoulos, Michail
Purcell, Mark Douglas
Conover, Damien
Le Berrigaud, Eric
Anderson, Timothy Minton
Choplain, Damien
Majumdar, Ishan
Talsania, Parth
Lee, Ji Hyun
Baudouin, Nicolas
Barker, Joseph Armstrong
Weston, Matthew
Vosser, Richard
Darout, Etzer
Kamadollishettaru, Amit
Flamme, Laurent
(This information refers to the last 90 days.)